Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S S Cross

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Histopathology|November 6, 2008
Expression of beta-dystroglycan is reduced or absent in many human carcinomasS S Cross, J Lippitt, A Mitchell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2000
What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polypsS S Cross, S Betmouni, J L Burton, et al.
British Journal of Cancer|July 29, 2004
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursorsI Rehman, S S Cross, A-R Azzouzi, et al.
Journal of Crohn'S & Colitis|October 15, 2014
Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remissionA J Brooks, S Sebastian, S S Cross, et al.
British Journal of Cancer|August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2G C Wishart, C D Bajdik, E Dicks, et al.
British Journal of Cancer|October 29, 2011
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer riskK N Stevens, M Garcia-Closas, Z Fredericksen, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Histopathology|November 6, 2008
Expression of beta-dystroglycan is reduced or absent in many human carcinomasS S Cross, J Lippitt, A Mitchell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2000
What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polypsS S Cross, S Betmouni, J L Burton, et al.
British Journal of Cancer|July 29, 2004
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursorsI Rehman, S S Cross, A-R Azzouzi, et al.
Journal of Crohn'S & Colitis|October 15, 2014
Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remissionA J Brooks, S Sebastian, S S Cross, et al.
British Journal of Cancer|August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2G C Wishart, C D Bajdik, E Dicks, et al.
British Journal of Cancer|October 29, 2011
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer riskK N Stevens, M Garcia-Closas, Z Fredericksen, et al.
Pageof 14